Medicared For All Logo

Mark Agulnik MD in Duarte, California

Home California Duarte

Mark Agulnik MD has Medical Oncology as his primary medical specialty. Their primary office is: 1500 Duarte Rd in Duarte, California. There is an additional office location, for a total of two, for Mark Agulnik MD that can be viewed further down.

They're a part of the: City Of Hope Medical Foundation medical group which has around 706 members. You can call their office at 626-256-4673 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1998 (around 26 years of experience). They are listed as doing telehealth appointments.


Mark Agulnik MD Office Phone and Directions

Mark Agulnik MD
City Of Hope Medical Foundation
1500 Duarte Rd
Duarte, California 91010
626-256-4673


Patient Ratings
Please rate your experience with Mark Agulnik MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 626-256-4673


Enter a starting address:


Healthcare Info for Mark Agulnik MD

Medical School: Sorry, his university is not listed
Graduation Year: 1998
The Primary Medical Specialty for Mark Agulnik MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 26
PAC (PECOS ID)#: 6406859388
NPI #: 1164448734
NPI Created On: 07/15/2006
NPI Last Updated Listed as: 11/27/2023
Primary Taxonomy Code: 207RX0202X
License Number:
036-118071
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: French.


Services and Procedures include:

  1. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  2. Infusion into a vein for therapy, prevention, or diagnosis
  3. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  5. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  6. Application of on-body injector for injection under skin
  7. Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
  8. Infusion of chemotherapy into a vein up to 1 hour
  9. Infusion of chemotherapy into a vein
  10. New patient office or other outpatient visit, typically 60 minutes
  11. Established patient office or other outpatient, visit typically 25 minutes
  12. Established patient office or other outpatient, visit typically 40 minutes
  13. Initial hospital inpatient care, typically 70 minutes per day
  14. Subsequent hospital inpatient care, typically 25 minutes per day
  15. Subsequent hospital inpatient care, typically 35 minutes per day
  16. Hospital discharge day management, more than 30 minutes
  17. Physician telephone patient service, 21-30 minutes of medical discussion
  18. Injection, denosumab, 1 mg
  19. Injection, dexamethasone sodium phosphate, 1 mg
  20. Injection, fosaprepitant, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $1,050

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 818636239

Being Disputed:: No

Product Related: No


Payments Total: $1,079

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 843582909

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: LIBTAYO

Open Associated Drug #1: 61755-008-01


Payments Total: $3,236

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 843582921

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: LIBTAYO

Open Associated Drug #1: 61755-008-01


Payments Total: $1,798

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 809554051

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: LIBTAYO

Open Associated Drug #1: 61755-008-01


Payments Total: $1,798

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 809554053

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: LIBTAYO

Open Associated Drug #1: 61755-008-01


Payments Total: $550

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 826793669

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: QINLOCK

Open Associated Drug #1: 73207-101-31


Payments Total: $4,400

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 826793667

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: QINLOCK

Open Associated Drug #1: 73207-101-31


Payments Total: $600

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 826793671

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: QINLOCK

Open Associated Drug #1: 73207-101-31


Payments Total: $1,500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 826793673

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: QINLOCK

Open Associated Drug #1: 73207-101-31


Payments Total: $525

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 826793675

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: QINLOCK

Open Associated Drug #1: 73207-101-31


Additional Office Locations

1. City Of Hope Medical Foundation
209 Fair Oaks Ave
South Pasadena, CA 91030
Group Members: 706

Phone: 626-256-4673

Enter a starting address:


Medical Oncology Professionals in Duarte

1500 Duarte Rd
Duarte, CA
City Of Hope Medical Foundation

1500 Duarte Rd
Duarte, CA
City Of Hope Medical Foundation

1500 Duarte Rd
Duarte, CA
City Of Hope Medical Foundation

1500 Duarte Rd
Duarte, CA
City Of Hope Medical Foundation

1500 Duarte Rd
Duarte, CA
City Of Hope Medical Foundation

1500 Duarte Rd
Duarte, CA
City Of Hope Medical Foundation

Providers in City Of Hope Medical Foundation

1.Sherwin Abdoli

1500 Duarte Rd
Duarte Ca 91010-3012
City Of Hope Medical Foundation
General Surgery

2.Wajidah Abdul-khabir

1500 Duarte Rd
Duarte Ca 91010-3012
City Of Hope Medical Foundation
Hospitalist

3.Wajidah Abdul-khabir

209 Fair Oaks Ave
South Pasadena Ca 91030-1814
City Of Hope Medical Foundation
Hospitalist

4.Michelle Afkhami

1500 Duarte Rd
Duarte Ca 91010-3012
City Of Hope Medical Foundation
Pathology

5.Michelle Afkhami

209 Fair Oaks Ave
South Pasadena Ca 91030-1814
City Of Hope Medical Foundation
Pathology

6.Mouchammed Agko

1500 Duarte Rd
Duarte Ca 91010-3012
City Of Hope Medical Foundation
Plastic And Reconstructive Surgery

View all 706 members of City Of Hope Medical Foundation medical group